Health News Releases

  • Today February 14
February 13, 16:00
Angelalign Technology Inc. (6699.HK) Says a Preliminary European Court Ruling on Certain Software Features Will Have Minimal Impact on Users
Angelalign Technology Inc. (6699.HK) (“Angel”) said a ruling by the Unified Patent Court of Düsseldorf, Germany that it preliminarily cease its use of certain software functions that automatically upd
February 12, 15:22
We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties
Galderma (SIX: GALD), the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra® across nine diverse patients
February 11, 15:30
Kirin and Immunosens Launch Joint Development of a Self-Testing Service That Uses Urinary IgA to Visualize a Person’s Immune Status
Kirin Holdings Company, Limited (Kirin Holdings) and Immunosens Co., Ltd. (Immunosens) have begun the joint development of a unique “Self-Testing Service[1]” designed to visualize a person’s immune st
February 11, 15:13
Galderma Expands Restylane® Portfolio in Japan With Launch of OBT™ Hyaluronic Acid Injectables Restylane Defyne™ and Refyne™
Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT based hyaluronic acid injectables ever authorized in J
February 10, 17:30
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54421686&newsitemid=20260210380286&lan=en-US&ancho
February 06, 15:50
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing
Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Grou
February 06, 11:40
Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat® KMT2A + MRD Assay and Software to its industry-leading oncol
InterSystems earns four Best in KLAS awards for 2026
February 06, 10:50
InterSystems Honored with Four 2026 Best in KLAS Awards
InterSystems, a creative data technology provider powering more than one billion health records globally, today announced it has received four Global 2026 Best in KLAS awards. The company earned a #1
February 05, 13:40
China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA®
The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic medical device in China. It is intended
Lorient’s low degree of modification delivers a smooth injection experience and high biocompatibilit
February 02, 17:16
Aesthetic Brand Lorient Showcases K-Beauty Excellence at IMCAS World Congress 2026
Lorient, a premium aesthetic brand, announced that it has attracted global attention at the 27th IMCAS World Congress 2026 in Paris, garnering over 15,000 professionals and demonstrating its leadershi
February 02, 15:13
Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission
Galderma (SIX: GALD) today announced that the U.S. FDA has accepted the BLA resubmission for RelabotulinumtoxinA for the temporary improvement of moderate-to-severe glabellar lines (frown lines) and l
January 30, 15:34
Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity
Galderma (SIX: GALD) has unveiled findings from a global survey of peri- and post-menopausal women from nine countries exploring the impact of menopause on the skin at the International Master Course
January 30, 10:50
Organon Completes Divestiture of JADA® System to Laborie
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today the successful closing of the sale of its JADA®
January 29, 15:52
Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE® Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54404180&newsitemid=20260128993781&lan=en-US&anc
January 29, 15:24
Galderma Unveils ‘Wake Up To Restylane’, Underscoring Restylane as the Ideal Hyaluronic Acid Treatment for Always-On Natural Beauty
Galderma (SIX: GALD), the pure-play dermatology category leader, has launched ‘Wake Up To Restylane’, a global campaign that showcases Restylane as an everyday beauty ally. Aligned with the growing de
January 29, 10:40
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only
H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE® G immunoassay analyzers. Th
January 26, 16:11
Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced financial results for the fourth quarter and fiscal year 20
Concept Medical announces first patient enrollment in the STARS DAPT randomized clinical trial evalu
January 25, 13:30
Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES
Concept Medical Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.conceptmedical.com%2F&esheet=54401002&newsitemid=20260121338054&lan=en-US&anchor=Concept+Medical+Inc.&index=
January 25, 09:30
Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis
Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of a fully integrated immune repertoire and whole transcriptome analysis
January 23, 09:07
Innovative Research Unveils Potential of Pharmaceutically Processed Mica in Cancer Treatment
A South Korean research team has discovered that pharmaceutically processed mica (PMC), a mineral traditionally used in medicine, may help suppress the growth of non-small cell lung cancer (NSCLC) cel
January 23, 08:30
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the
Life-saving zinc-supplementation and oral rehydration salts kits are proactively distributed to Zamb
January 22, 14:30
International Zinc Association Partners With Pharmanova to Save Children in Zambia
Zinc Saves Kids, a global child‑health initiative of the International Zinc Association (IZA) (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.zinc.org%2F&esheet=54398808&newsite
January 22, 09:16
Galderma Provides Update on Arbitration Case Regarding Neuromodulator Research and Development Partnership
Galderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued an award confirming the termination of a 2014 neuromo
January 21, 15:20
Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory has achieved College of American Pathologists (CAP) accre
January 21, 13:50
Colgate-Palmolive and WHO Foundation Announce Global Partnership on Oral Health
Today, Colgate-Palmolive announced a new multi-year collaboration with the WHO Foundation to support the World Health Organization’s work on oral health. The four-year funding commitment will help exp
January 21, 11:50
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
Parse Biosciences and Graph Therapeutics (Graph) today announced a strategic partnership to create one of the largest and most comprehensive immune cell perturbation atlases. The collaboration will le
January 21, 10:40
WHOOP Becomes Official Health and Fitness Wearable Partner and Team Partner of Scuderia Ferrari HP
WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com%3Futm_source%3DPR%26utm_medium%3DPR%26utm_campaign%3DSR_A&esheet=54399604&newsitemid=20260119602892&lan=en-US&anc
Jeff Rowe, Syngenta Group CEO
January 19, 17:04
Syngenta to Address Global Agricultural Challenges at WEF, Championing AI to Empower Farmers and Create Open Technology Access
As farmers globally grapple with unprecedented economic, geopolitical, and environmental pressures; the agricultural sector faces a continued contraction. An alarming decrease in active farms worldwid
January 18, 13:45
WEP Clinical Acquires Netherlands-Based CRO Siron Clinical, Expanding Global Phase I-IV Trial Delivery Capabilities
WEP Clinical (WEP) (https://www.wepclinical.com/), a full-service contract research organization (CRO), announces the acquisition of Siron Clinical (Siron) (https://sironclinical.com/), a Netherlands-
January 16, 15:10
Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness
Agenus Inc. (https://www.agenusbio.com/) (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences
Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC.
January 16, 11:20
QPS Selects Oracle Argus Safety Database to Enhance Pharmacovigilance in Clinical Trials
QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovig
January 15, 15:10
Notice Concerning Change of Representative Executive Officer
H.U. Group Holdings, Inc. (the Company) today announced that it has resolved, at a meeting of the Board of Directors held on January 14, 2026, to change the Company’s Representative Executive Officer
January 15, 10:40
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures wit
Kyung-Ah Kim, President and Chief Executive Officer (CEO) of Samsung Epis Holdings
January 15, 10:03
Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference
Samsung Epis Holdings (KRX: 0126Z0) today shared corporate progress and updates at the 44th J.P. Morgan Healthcare Conference. “2026 is a monumental year for us, as we enter into a new chapter for
January 14, 17:05
France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas
Agenus Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.agenusbio.com&esheet=54393958&newsitemid=20260112699965&lan=en-US&anchor=Agenus+Inc&index=1&md5=e3584ab25f74ab4a2ec4f1
January 14, 16:32
TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics
Galderma (SIX: GALD) will present data on its innovative and industry-leading neuromodulator portfolio at the TOXINS 2026 International Conference in Madrid, Spain from January 14-17, 2026. The compan
January 14, 15:20
BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference
BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbeonemedicines.com%2F&esheet=54394840&newsitemid=20260113426214&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)
January 13, 14:00
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement desig
January 13, 09:02
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic tr
January 11, 10:45
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administra
January 09, 15:00
ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA
BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZII
Dr. Anand Tharmaratnam, Novotech CEO and Chairman
January 08, 16:50
Novotech Appoints Anand Tharmaratnam as New CEO
Novotech, a globally recognized full-service biotech clinical research organization (CRO), is pleased to announce the appointment of Dr. Anand Tharmaratnam as its new Chief Executive Officer. Dr. T
January 06, 16:40
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq
Cybin Inc. (the “Company”) doing business as Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (“Helus Pharma”), a clinical stage pharmaceutical company committed to helping minds heal by developing NSAs,
January 06, 09:12
Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform
Clonell Therapeutics, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.clonell.com%2F&esheet=54386221&newsitemid=20260105515302&lan=en-US&anchor=Clonell+Therapeutics%2C+Inc.&
January 06, 09:04
Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54386774&newsitemid=20260101831438&lan=en-US&anchor=TSE%3A4
January 05, 09:06
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua High Court’s interlocutory order gov
January 05, 08:54
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2,
Aster Guardians Global Nursing Award worth USD 250,000 (Photo: AETOSWire)
January 02, 17:00
Aster Guardians Global Nursing Award 2026 Worth $250,000 Extends Deadline Till 11th January 2026
The Aster Guardians Global Nursing Award 2026, an initiative from Aster DM Healthcare - a leading integrated healthcare provider, has announced the extension of its deadline to January 11, 2026. The a
World's first international patient, who received intrathecal gene therapy at Medcare Royal Hospita
December 31, 2025 14:15
UAE’s Medcare Treats First International SMA Patient With Revolutionary Intrathecal Gene Therapy
Medcare Women & Children Hospital has successfully administered a pioneering intrathecal gene therapy for Spinal Muscular Atrophy (SMA) to Hulus, a three-year-old patient from Turkey. This milestone p
December 23, 2025 09:19
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor
Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of
25 per page50 per page75 per page100 per page